Gastroenterology
News from the FDA/CDC
FDA Approves 10th Humira Biosimilar, With Interchangeability
Adalimumab-ryvk (Simlandi) is the first adalimumab biosimilar in a high-concentration formulation to receive interchangeability status from the...
News
What Skin Manifestations Are Associated With Pediatric IBD?
The most common noninfectious dermatologic condition among the 425 children and adolescents was acne, followed by eczema.
News
FDA Approves Drug to Reduce Accidental Food Allergies
Asthma drug approved to reduce reaction to food allergies.
News
New Guideline Offers Recommendations for Alcohol-Associated Liver Disease
The guidelines note the importance of policy aimed at alcohol use reduction, multidisciplinary care for alcohol use disorder and alcohol-...
News
Migraine Associated With Increased Risk for IBD
Population-based study finds link between migraine and increased risk of IBD, Crohn’s, and UC.
Conference Coverage
Wearable Device Tracks IBD from Sweat
If perfected, noninvasive method could improve patient management and provide more granular data for clinical studies.
Commentary
The Breakthrough Drug Whose Full Promise Remains Unrealized
With its approval in 2013, sofosbuvir revolutionized the treatment of hepatitis C, but the goal of eliminating this disease is still decades away...
Commentary
Tips and Techniques to Boost Colonoscopy Quality
David A. Johnson, MD, shares tips and tricks learned in his practice to improve the quality of colonoscopies.
News
Ozempic is Appealing, but Not Cost-Effective, for Obesity Treatment
Surgical and endoscopic options to treat obesity are cost effective, but not the pharmacological intervention semaglutide.
News
Artificial Sweeteners Alter the Duodenal Microbiome
Nonsugar sweeteners were found to change diversity of the intestinal microbiome and level of inflammatory markers.